AdvaMed's Plea on Medical Device Tariffs
AdvaMed seeks to collaborate with the Trump administration to acknowledge the unique strength of the U.S. medtech industry.
AdvaMed CEO and President Scott Whitaker stated that his group wants to work with the administration
"to recognize and to reward the unique strength of the U.S. medtech industry"through supportive policies.
- Seeking fair and reciprocal tariff-free trade with key allies
- Addressing unfair market access barriers in specific countries
- Advancing domestic regulatory reforms and procurement incentives to enhance U.S. competitiveness
AdvaMed provided an overview of the domestic medtech industry, highlighting recent investments, employment growth, and R&D spending driving medical innovation, in comments submitted to Commerce Secretary Howard Lutnick.
Author's summary: AdvaMed seeks Trump administration support for medtech industry.